Penumbra Inc Stock Price, News & Analysis

Penumbra, Inc. (NYSE: PEN) will host a conference call to discuss its second quarter 2022 financial results on August 4, 2022, at 4:30 PM Eastern Time. The results will be released after market close on the same day. The conference call can be accessed via phone or through a webcast available on the company's website. Penumbra focuses on innovative therapies to meet significant unmet medical needs, supporting healthcare providers in over 100 countries.

Penumbras, Inc. (NYSE: PEN) reported Q1 2022 revenues of $203.9 million, reflecting a 20.5% increase from Q1 2021. Vascular product sales surged 37.7% to $122.8 million, while neuro product revenues grew modestly by 1.3% to $81.1 million. Despite revenue growth, the gross profit decreased to 62.5% of total revenue, down from 65.8% a year ago, impacted by rising labor and logistics costs. Operating expenses increased substantially to $131.5 million, resulting in an operating loss of $4.0 million for the quarter.

Penumbra, Inc. (NYSE: PEN) will present at the Bank of America Securities 2022 Healthcare Conference on May 10, 2022, at 4:40 PM PT / 7:40 PM ET. The event will provide insights into the company's innovative healthcare solutions and strategies. A webcast of the presentation will be available on Penumbra's website for two weeks post-event. Headquartered in Alameda, California, Penumbra designs and markets therapies addressing significant medical needs globally.

Penumbra, Inc. (NYSE: PEN) has launched its advanced Indigo Aspiration System technologies, Lightning 7 and Lightning 12, in Europe following CE Mark approval. These systems, focused on mechanical thrombectomy for removing blood clots in a single session, aim to enhance patient outcomes by differentiating between clot and blood to minimize blood loss. Physicians in Europe now have access to this innovative technology, which has already shown success in the U.S. market, potentially reducing ICU stays and improving care efficiency.

Penumbra, Inc. (NYSE: PEN) will host a conference call on May 3, 2022, at 4:30 PM ET to discuss its first-quarter 2022 financial results. A press release detailing these results will be issued after market close that day. Investors can access the call through a phone line or via a webcast on the company's website. Penumbra focuses on innovative healthcare solutions and operates in over 100 countries, creating products that address significant medical needs.

Penumbra, Inc. (NYSE: PEN) has launched the REAL Immersive System y-Series, expanding its virtual reality healthcare platform. This new offering enhances patient care with upgraded hardware and a broader activity library for rehabilitation therapy. The platform now addresses conditions affecting over 50 million patients in the U.S. The improved interface, TherapyView™, allows clinicians to customize therapy programs, engaging patients more effectively. The y-Series was showcased at the American Occupational Therapy Association Annual Conference in San Antonio, TX.

Penumbra, Inc. (NYSE: PEN) is set to present at the 21st Annual Needham Virtual Healthcare Conference on April 11, 2022, at 3:00 PM ET. The event will showcase Penumbra's innovative therapies and its commitment to addressing challenging medical conditions.

Investors can access the presentation via a webcast on the company's website, available for two weeks post-event. Penumbra operates globally, supporting healthcare providers in over 100 countries with a robust portfolio aimed at significant unmet medical needs.

Penumbra, Inc. (NYSE: PEN) reported financial results for Q4 and full year 2021, with Q4 revenue reaching $204.0 million, a 22.2% increase from Q4 2020. Full year revenue totaled $747.6 million, up 32.6% year-over-year. US revenue represented 71% of total revenue, with vascular products growing 30.4% to $113.6 million in Q4. Despite higher operating expenses, non-GAAP operating income was $2.5 million for Q4. The company forecasts 2022 revenue between $860 million and $875 million, indicating 15% to 17% growth.

Penumbra, Inc. (NYSE: PEN) is set to present at Citi's 2022 Virtual Healthcare Conference on February 24, 2022, at 1:15 PM ET.

Investors can access the presentation via a webcast on the company's website, which will remain available for at least two weeks after the event. Penumbra, headquartered in Alameda, California, specializes in innovative healthcare therapies and serves clients in over 100 countries. For further details, visit www.penumbrainc.com.